CombiMatrix Likely to Spin Out From Acacia In Q1 2007 as Firm Banks on CMDX Pipeline | GenomeWeb
CombiMatrix will likely spin off from parent company Acacia Research by the first quarter of 2007, roughly six months after it had originally anticipated doing so.
 
At the same time, the firm’s CombiMatrix Molecular Diagnostics subsidiary is readying a suite of diagnostic tests that it believes will put it ahead of rivals in the array-based molecular diagnostic space next year.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.